Home>>Signaling Pathways>> Others>>PEO-IAA (2-(1H-Indol-3-yl)-4-oxo-4-phenyl-butyric acid)

PEO-IAA (2-(1H-Indol-3-yl)-4-oxo-4-phenyl-butyric acid)

Catalog No.GC30168

PEO-IAA (2-(1H-Indol-3-yl)-4-oxo-4-phenyl-butyric acid) is an indole-3-acetic acid (IAA) antagonist.

Products are for research use only. Not for human use. We do not sell to patients.

PEO-IAA (2-(1H-Indol-3-yl)-4-oxo-4-phenyl-butyric acid) Chemical Structure

Cas No.: 6266-66-6

Size Price Stock Qty
10mM (in 1mL DMSO)
$71.00
In stock
10mg
$65.00
In stock
50mg
$193.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

PEO-IAA is an indole-3-acetic acid (IAA) antagonist. PEO-IAA is an auxin antagonist that binds to transport inhibitor response 1/auxin signaling F-box proteins (TIR1/AFBs).

PEO-IAA is also an α-alkyl-IAA, and shows more potent anti-auxin activity in auxin-responsive gene expression and in the cell division and elongation pathway that is mediated via SCFTIR1/AFBs. PEO-IAA suppresses not only the expression of an auxin-responsive ZmSAUR2 gene, but also gravitropic curvature. PEO-IAA blocks the auxin response in Arabidopsis, rice, moss and maize[1].

[1]. Nishimura T, et al. Differential downward stream of auxin synthesized at the tip has a key role in gravitropic curvature via TIR1/AFBs-mediated auxin signaling pathways. Plant Cell Physiol. 2009 Nov;50(11):1874-85.

Reviews

Review for PEO-IAA (2-(1H-Indol-3-yl)-4-oxo-4-phenyl-butyric acid)

Average Rating: 5 ★★★★★ (Based on Reviews and 34 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for PEO-IAA (2-(1H-Indol-3-yl)-4-oxo-4-phenyl-butyric acid)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.